This company listing is no longer active
Igeamed Past Earnings Performance
Past criteria checks 0/6
Igeamed's earnings have been declining at an average annual rate of -21.7%, while the Professional Services industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 6.8% per year.
Key information
-21.7%
Earnings growth rate
n/a
EPS growth rate
| Professional Services Industry Growth | 30.0% |
| Revenue growth rate | 6.8% |
| Return on equity | -2.6% |
| Net Margin | -0.3% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Igeamed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 8 | 0 | 0 | 0 |
| 30 Sep 22 | 8 | 0 | 0 | 0 |
| 30 Jun 22 | 8 | 0 | 0 | 0 |
| 31 Mar 22 | 8 | 0 | 0 | 0 |
| 31 Dec 21 | 8 | 0 | 0 | 0 |
| 30 Sep 21 | 8 | 0 | 0 | 0 |
| 30 Jun 21 | 8 | 0 | 0 | 0 |
| 31 Mar 21 | 8 | 0 | 0 | 0 |
| 31 Dec 20 | 7 | 0 | 0 | 0 |
| 31 Dec 19 | 7 | 0 | 0 | 0 |
| 31 Dec 18 | 7 | 0 | 0 | 0 |
| 31 Dec 17 | 5 | 0 | 0 | 0 |
| 31 Dec 16 | 4 | 0 | 0 | 0 |
| 31 Dec 15 | 2 | 0 | 0 | 0 |
| 31 Dec 14 | 2 | 0 | 0 | 0 |
Quality Earnings: MED is currently unprofitable.
Growing Profit Margin: MED is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MED is unprofitable, and losses have increased over the past 5 years at a rate of 21.7% per year.
Accelerating Growth: Unable to compare MED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MED is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (9.1%).
Return on Equity
High ROE: MED has a negative Return on Equity (-2.61%), as it is currently unprofitable.